Join to View Full Profile
125 Nashua StreetSrhBoston, MA 02114
Phone+1 617-573-2742
Fax+1 617-573-2759
Are you Dr. Krivickas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lisa Krivickas, MD is a physiatrist in Boston, Massachusetts.
Publications & Presentations
PubMed
- 42 citationsA randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosisLora Clawson, Merit Cudkowicz, Lisa S. Krivickas, Benjamin Rix Brooks, Mohammed Sanjak
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2018-04-03 - 14 citationsSystemic Pharmacokinetics and Cerebrospinal Fluid Uptake of Intravenous Ceftriaxone in Patients with Amyotrophic Lateral SclerosisYanli Zhao, Merit Cudkowicz, Jeremy M. Shefner, Lisa S. Krivickas, William S. David
Journal of Clinical Pharmacology. 2014-10-01 - 71 citationsDesign and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral SclerosisJames D. Berry, Jeremy M. Shefner, Robin Conwit, David A. Schoenfeld, Myles Keroack
Plos One. 2013-04-17
Press Mentions
How the Healy ALS Platform Trial Is Helping to Accelerate the Pathway to New ALS TreatmentsDecember 5th, 2024
Dr. Sabrina Paganoni Celebrated for Impact on ALS ResearchOctober 3rd, 2019
Grant Support
- Clinical Trial: Clinical Trial Of High Dose COQ10 In ALSNational Center For Research Resources2008
- Clinical Trial: Clinical Trial Of Ceftriaxone In Subjects With ALSNational Center For Research Resources2008
- Clinical Trial Of Ceftriaxone In Subjects With ALSNational Center For Research Resources2007
- Clinical Trial Of High Dose COQ10 In ALSNational Center For Research Resources2006–2007
